Valsartan

Dept of Defense · United States government procurement

Get new United States Pharmaceuticals tenders by email, free: Set up alerts

GlobalGov surfaces government procurement from around the world, including the markets your competitors overlook.

$14.5M
Est. Value
May 04, 2027
Response Due
Active
Status

Want more tenders like this one?

We will email you a free list of open Pharmaceuticals tenders in the United States, usually within 10 minutes. No account needed.

About this record

The issuing agency did not publish a detailed description for this notice. The full record as GlobalGov received it is below.

Tenders like this are published on a national procurement portal that most bidders outside the United States never check.

How to bid: GlobalGov tracks this tender; it does not accept bids. Submit your response through the issuing agency’s official notice.

Bidding on this? Book 15 minutes with us and we will pull the documents, past awards and a translation for this tender live with you. Book a walkthrough

Your competitors are watching the same crowded contracts everyone else is. Track this opportunity and every one like it worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, cancel anytime.

Start a free GlobalGov account

Solicitation Details

Issuing agencyDept of Defense
CountryUnited States
CategoryPharmaceuticals
Estimated value$14.5M
NAICS325412 - Pharmaceutical Preparation Manufacturing
PSC6505
PublishedSeptember 24, 2025
Procurement stageRequest for Proposal (RFP)
Response dueMay 04, 2027
StatusOpen — accepting responses
Official sourceView original notice Track this tender · Get the tender pack: $49, delivered within 24h
Last verifiedNovember 22, 2026

Source: U.S. Government (SAM.gov) — public domain. GlobalGov is not affiliated with or endorsed by the United States Government.

Related Opportunities in United States

Febuxostat National Contract
Olopatadine HCL 0.1% Ophthalmic Solution
Furosemide Tablets
Accelerating Research and Development of Next Generation Vaccines against Malaria - a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed)
Translational Bioinformatics and Experimental Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimers Disease and Related Dementias (R01 Clinical Trial Not Allowed)
Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)
National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders (U19 Clinical Trial Optional)
Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)

See every United States Pharmaceuticals opportunity your competition is missing. Free for 14 days.

Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.

Start Your 14-Day Free Trial

Free 14-day trial · cancel anytime

See who is already competing here →